Fujifilm Photography News and Rumors

Significant expansion of production facilities for biopharmaceuticals in Denmark
Accelerate expansion of outsourced biopharmaceutical development and manufacturing business with large investment of 100 billion yen

Doubled the production capacity of the drug substance, and established a contracted system that allows one-site, one-stop support from the drug substance to formulation and packaging

FUJIFILM Corporation (President: Kenji Sukeno ) will be the Danish base of FUJIFILM Diosynth Biotechnologies (FDB), which is the core company of biopharmaceutical CDMO ^*2 , in order to accelerate the expansion of contracted development and manufacturing business of biopharmaceuticals ^*1. We will make a large capital investment of about 100 billion yen. This investment will significantly expand biopharmaceutical manufacturing facilities, including the addition of drug substance manufacturing facilities and the establishment of new drug product manufacturing lines. FUJIFILM will sequentially operate the increased manufacturing facilities from 2022 to 2023 to double the production capacity of biopharmaceutical drug substances at the Danish site, and at the same site, one-site/one-stop from drug substance to drug product/packaging. We will build a system for outsourced manufacturing. Read More »